et_companies2 days ago
BEARISH(90%)
hold
Plastic price surge hits MSMEs, disrupts supply chains for FMCG and footwear firms
Read original source-60.5
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The pharma sector, while generally resilient, relies heavily on plastic for packaging, medical devices, and disposables. Rising plastic costs will directly impact manufacturing expenses and potentially lead to pricing pressures or margin contraction.
Trading Insight
Monitor pharma companies' raw material cost structures and packaging dependencies; consider a cautious stance on those with high exposure to plastic input costs.
Quick check: SUNPHARMA neutral (-1.4% 1d), CIPLA bearish bias (-1.4% 1d).
Key Evidence
- •Plastic processing units in Kerala are halting operations due to rising raw material costs and capital shortages.
- •The issue impacts FMCG, footwear, and healthcare sectors.
- •Manufacturers have increased prices by up to 50%, with further hikes anticipated.
- •Supply chains are facing disruptions.
- •Industry leaders are urging government intervention.
Affected Stocks
Negative
Increased input costs due to plastic price surge will impact margins and potentially lead to higher consumer prices, affecting demand.
Negative
Reliance on plastic components will lead to higher manufacturing costs and potential supply chain disruptions.
Negative
Increased costs for plastic-based medical devices, packaging, and disposables will impact operational expenses.
AI-powered analysis by
Anadi Algo News